The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Vaccination of MSI-H colorectal cancer patients with frameshift peptide antigens: A phase I/IIa clinical trial.
Matthias Kloor
No relevant relationships to disclose
Miriam Reuschenbach
No relevant relationships to disclose
Julia Karbach
No relevant relationships to disclose
Mohammad-Reza Rafiyan
No relevant relationships to disclose
Salah-Eddin Al-Batran
No relevant relationships to disclose
Claudia Pauligk
No relevant relationships to disclose
Elke Jaeger
Research Funding - ORYX
Magnus von Knebel Doeberitz
Research Funding - ORYX